479 related articles for article (PubMed ID: 34697224)
1. CSF Findings in Acute NMDAR and LGI1 Antibody-Associated Autoimmune Encephalitis.
Dürr M; Nissen G; Sühs KW; Schwenkenbecher P; Geis C; Ringelstein M; Hartung HP; Friese MA; Kaufmann M; Malter MP; Madlener M; Thaler FS; Kümpfel T; Senel M; Häusler MG; Schneider H; Bergh FT; Kellinghaus C; Zettl UK; Wandinger KP; Melzer N; Gross CC; Lange P; Dreyhaupt J; Tumani H; Leypoldt F; Lewerenz J;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34697224
[TBL] [Abstract][Full Text] [Related]
2. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
Front Immunol; 2021; 12():646940. PubMed ID: 33828556
[TBL] [Abstract][Full Text] [Related]
4. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
5. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
Pişkin ŞA; Korkmaz HY; Ulusoy CA; Şanlı E; Küçükali CI; Onat F; Tüzün E; Çarçak N
Front Immunol; 2023; 14():1268986. PubMed ID: 38035091
[TBL] [Abstract][Full Text] [Related]
6. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
[TBL] [Abstract][Full Text] [Related]
7. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
[TBL] [Abstract][Full Text] [Related]
8. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW
J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal B-cell activation in LGI1 antibody encephalitis.
Lehmann-Horn K; Irani SR; Wang S; Palanichamy A; Jahn S; Greenfield AL; Dandekar R; Lepennetier G; Michael S; Gelfand JM; Geschwind MD; Wilson MR; Zamvil SS; von Büdingen HC
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32029531
[TBL] [Abstract][Full Text] [Related]
10. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
11. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
[TBL] [Abstract][Full Text] [Related]
12. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
14. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
[TBL] [Abstract][Full Text] [Related]
16. Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability.
Kornau HC; Kreye J; Stumpf A; Fukata Y; Parthier D; Sammons RP; Imbrosci B; Kurpjuweit S; Kowski AB; Fukata M; Prüss H; Schmitz D
Ann Neurol; 2020 Mar; 87(3):405-418. PubMed ID: 31900946
[TBL] [Abstract][Full Text] [Related]
17. Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens.
Klein da Costa B; de Oliveira Pinto P; Staub L; Hansel G; Vanik Pinto G; Porcello Schilling L; Rodrigues Dos Passos G; Alves Martins W; Becker J; Machado Castilhos R; Palmini A; Sato DK
Mult Scler Relat Disord; 2023 Dec; 80():105022. PubMed ID: 37864878
[TBL] [Abstract][Full Text] [Related]
18. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.
Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y
Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis.
Muñiz-Castrillo S; Haesebaert J; Thomas L; Vogrig A; Pinto AL; Picard G; Blanc C; Do LD; Joubert B; Berzero G; Psimaras D; Alentorn A; Rogemond V; Dubois V; Ambati A; Tamouza R; Mignot E; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33848259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]